Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer
Clinical trial NCT02743923 · UNKNOWN
Trial details
- NCT number
- NCT02743923
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2021-09-19
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.